SCHEMBL9257874

SCHEMBL9257874

CCCCC(=O)NCCCCCCCCCCCC(=O)O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.76
CASP2 P42575 1/20 0.66
KDM4E B2RXH2 1/20 0.65
PLA2G2A P14555 1/20 0.64
FAAH O00519 5/20 0.62
NAAA Q02083 1/20 0.61
ADRA1A P35348 1/20 0.60
CNR1 P21554 2/20 0.59
CNR2 P34972 2/20 0.59
PPARG P37231 4/20 0.59
PPARD Q03181 4/20 0.59
PPARA Q07869 4/20 0.59
TSHR P16473 3/20 0.59
GPR84 Q9NQS5 3/20 0.59
HDAC11 Q96DB2 3/20 0.59
ALDH1A1 P00352 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
TLR2 O60603 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20844943 1.00 EPHX2 (0.76) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL9827881 1.00 EPHX2 (0.76) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL9829191 0.98 EPHX2 (0.73) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL15259281 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL22684645 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL23052005 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL22072061 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL2150959 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL9266547 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH
SCHEMBL8044633 0.96 EPHX2 (0.81) EPHX2CASP2KDM4EPLA2G2AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP claimed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP claimed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed